Abstract:Retinopathy of prematurity (ROP) is a relatively late manifestation in preterm and very low birth weight (VLBW) survivors; thus, increasing survival rates among extremely preterm infants will necessarily result lead to increased incidence and more severe ROP. 1,2 ROP incidence is strongly and inversely linked to gestational age suggesting that a more immature landscape and/or prolonged exposure to noxious agents and environmental stimuli such as excess oxygen and inflammation underlie this relationship. 3 However, some extremely preterm infants escape the neonatal intensive care unit without ROP despite abundant exposure to oxygen and repeat episodes of sepsis/inflammation while other preterm infants with rather uneventful courses reach threshold ROP. With these observations, we seek other explanatory variables for the exceptions to the rules. Gene loci that infer susceptibility to or protection from ROP have long been sought with much of this focus on candidate genes linked to capillary formation. Somewhat surprisingly, no variants of vascular endothelial growth factor (VEGF), the putative driver of angiogenesis, or its receptor have been identified in genome wide association studies with ROP although candidate gene approaches have identified SNP variants in VEGF signaling associated with ROP. 4 Several candidate genes have been proposed as "risk factors" for ROP but these associations often fail to be confirmed in separate populations. In this issue of Pediatric Research , Gimenez and colleagues selected nine candidate genes linked to ROP in a preterm population in the United States for validation studies in their own preterm population from Argentina. 5 In both populations, the rs1868085 polymorphism in the EPAS1 gene associated with ROP. Not surprisingly, EPAS1 encodes the hypoxia inducible factor-2α (HIF-2α) transcription factor, which is closely linked to capillary formation through its regulation of VEGF and other oxygen-sensitive angiogenic genes. The convergence of these linkage studies on EPAS1 is encouraging that a "universal" genetic susceptibility locus for ROP may be identified. The authors identify other SNPs in their sample that associate with ROP including the angiotensin II receptor gene but fail to recognize some SNPs that appear to be similarly linked including the rs699947 polymorphism in VEGF (OR 0.42, CI: 0.15–1.18). Although this variant does not reach "statistical significance", VEGF is directly linked to HIFs and angiotensin II signaling and should be considered as a candidate SNP in future studies.

Genetic susceptibility for retinopathy of prematurity and its associated comorbidities

Genetic Susceptibility to Retinopathy of Prematurity

Genetic Basis for Susceptibility to Retinopathy of Prematurity

Genetic risk and retinopathy of prematurity: homing in on a target?

Genetic variants of the beta-adrenergic receptor pathways as both risk and protective factors for retinopathy of prematurity.

[Evaluation of Risk Factors for Retinopathy of Prematurity].

Genome-wide association identifies novel ROP risk loci in a multiethnic cohort

Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985–2021): A Systematic Review and Meta-Analysis

Gut Microbiome and Retinopathy of Prematurity

Incidence and Risk Factor Analysis of Retinopathy of Prematurity

Retinopathy of Prematurity in Eight Portuguese Neonatal Intensive Care Units: Incidence, Risk Factors, and Progression-A Prospective Multicenter Study

Retinopathy of prematurity screening: prevalence and risk factors of ophthalmic complications in non-treated preterm infants

Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants

Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico

Retinopathy of prematurity: contribution of inflammatory and genetic factors

Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis

Hyperbilirubinemia and retinopathy of prematurity: a retrospective cohort study

Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Analysis of factors of spontaneous regression of prematurity retinopathy

Evaluation of the prematurity retinopathy and other eye changes in the newborn